NUCLEIC ACID TESTING MARKET ANALYSIS

Nucleic Acid Testing Market, By Product Type (Nucleic Acid Test Kits (Polymerase Chain Reaction (PCR), Ligase Chain Reaction (LCR), Transcription–mediated Amplification (TMA), Whole Genome Sequencing) and Consumables), By Indication (Infectious Disease, Cancer, Forensic Testing, Personalized Medicine, and Others), By End User (Hospitals & Clinics, Pathology Laboratories, and Academic & Research Organization) and By Geography - Global Industry Insights, Trends, Outlook and Opportunity Analysis, 2022-2028

To Be Published : Dec 2024
Code : CMI1644
Formats :
Excel and PDF
Industry : Biotechnology

Market Challenges And Opportunities

Nucleic Acid Testing Market – Restraint

The inability or difficulty of nucleic acid testing in obtaining quantitative results from a large pool of clinical sample, difficulty of using NAT test for susceptibility testing, and higher cost of nucleic acid testing devices is expected to hamper growth of the nucleic acid testing market. According to the data published in Asian Journal of Transfusion Science, in February 2014, NAT is highly sensitive and advanced technique, however, it is associated with high cost and requires dedicated infrastructure facility, equipment, consumables, and technical expertise.

NUCLEIC ACID TESTING MARKET ANALYSIS

Market Challenges And Opportunities

Nucleic Acid Testing Market Report Snapshots

EXISTING CLIENTELE